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Abstract 
 
Glass-ceramic scaffolds mimicking the structure of cancellous bone were produced via sponge 
replication technique by using a polyurethane foam as template and glass powder below 30 m as 
inorganic phase. Specifically, a SiO2-based glass of complex composition and its corresponding 
P2O5-based “specular” glass were used as materials for scaffolding. The polymeric sponge was 
thermally removed and the glass powders were sintered to obtain a replica of the template structure. 
The scaffolds were investigated and compared from a structural, morphological and mechanical 
viewpoint by assessing their crystalline phases, volumetric shrinkage, pores content and 
interconnection, mechanical strength. In addition, the scaffolds were soaked in acellular simulated 
body fluid to investigate their in vitro behaviour. The produced scaffolds have a great potential for 
bone reconstructive surgery because their features, such as shape, strength, bioactivity and 
bioresorption, can be easily tailored according to the end use. 
 
Keywords: Scaffolds; silica and phosphate-based glass-ceramics; Bioactivity; Bioresorption; Bone 
grafting. 
 
 
 
 
 
 
 
 
 
  
1 Introduction 
 
Since early 1970s, bioceramics have been widely investigated in orthopaedics, maxillo-facial 
surgery and dentistry for the substitution of small or extensive bone portions due to trauma, tumours 
removal, age-related diseases (osteoporosis, osteoarthritis) or other pathologies [1-3]. The use of 
alloplastic materials allows to overcome the main drawbacks of traditional autografts (low 
availability, risk of pain and death of healthy tissue at the donor site) and homografts (risk of 
disease transmission, need of immunosuppressant drugs for the patient) [4].  
Hydroxyapatite (HA) has been traditionally proposed for hard-tissue repair because of its chemical 
and crystallographic similarity to the carbonated apatite in human bone and teeth [5]. Calcium 
phosphate (CaP) salts, such as -tricalcium phosphate (-TCP) or -calcium pyrophosphate (-
CPP), can act as HA precursors and they have been usually adopted in dentistry [6-7]. HA and CaP 
scaffolds exhibit an excellent biocompatibility but they are characterized by poor mechanical 
strength (below 1 MPa) [8-9] in comparison with that of cancellous bone (2-12 MPa) [10-11]. 
Bioactive glasses (BGs) and glass-ceramics (BGCs) have attracted the interests of many researchers 
because their properties can be tailored depending on glass composition. The word “bioactivity” 
was coined by Hench in 1971 when he and his colleagues synthesized Bioglass
®
 [12]. Bioactivity 
denotes the ability to elicit a specific biological response at the interface of the material which 
results in formation of a bond between tissue and material [13-15]. BGs and BGCs contain silicon 
dioxide (SiO2) as the network former and alkaline/alkaline-earthy metal oxides (Na2O, K2O and 
CaO) as network modifiers able to promote the sequence of reactions involved in the bioactive 
process when the implant is exposed to body fluids. The bonding of BGs has been attributed to the 
formation of a HA or apatite-like layer, similar to bone mineral, on the glass surface.  
BGs and BGCs can be produced in two ways: (i) melt processing, followed by pouring into moulds 
or quenching into cold water to obtain a “frit”, or (ii) sol-gel route. Hench demonstrated that melt-
derived glasses can be bioactive only if the silica content is less than 60 %mol. [13]. However, sol-
  
gel glasses with up to 90 %mol. silica reveal a bioactive behaviour due to their high specific surface 
area, typically within 100-200 m
2∙g-1, which promotes ion-exchange phenomena with biological 
fluids [16-18]. 
In the last decade, biocompatible degradable materials have attracted increasing interests in the field 
of tissue engineering. Calcium phosphate-based glasses (CaP-Gs) offer a unique range of soluble 
materials whose degradation rate can be foreseen by tailoring the glass composition. CaP-Gs belong 
to the basic system P2O5–CaO–Na2O, in which phosphorus pentoxide is the network former. It is 
possible to design the composition of CaP-Gs, according to the end use, by incorporating metal 
oxides, such as F2O3 [19], TiO2 [20] and ZnO [21], at the expense of CaO and/or Na2O. SiO2 can be 
added to the composition because, disrupting the P2O5-based network, enhances glass solubility. 
CaP-Gs are degradable with resorption rate that matches bone healing and cells regeneration rate 
[22], and their products of degradation are tolerated by the body without the risk of inflammation 
[23]. In addition CaP-Gs, usually produced by a melting-quenching route, can be molten at low 
temperature if compared to silica-based glasses. 
HA, CaP salts, BGs and CaP-Gs have been proposed and investigated as bone fillers in form of 
particulate and as materials for scaffolding. Scaffolds are usually 3-D porous templates aiming to 
temporarily repair or restore the body after disease or degeneration [24]. Scaffolds for bone tissue 
engineering should (i) be biocompatible, (ii) promote osteoblasts adhesion and activity stimulating 
osteogenesis, (iii) bond to the living bone creating a stable interface, (iv) possess mechanical 
properties (strength, stiffness) matching those of the surrounding bone and (v) be easily fabricated 
in a reproducible way to match the size and shape of bone defects. 
The purpose of this study was the preparation and characterization of foam-like inorganic scaffolds 
for bone tissue engineering produced by using (i) a SiO2-based glass and (ii) the corresponding 
P2O5-based “specular” glass. The scaffolds were fabricated by the sponge-replication technique [25-
27]. The major novelty is that for the first time – in the authors’ knowledge – scaffolds based on a 
  
couple of silicate/phosphate “specular” glasses were compared in detail as regards their structural, 
morphological and mechanical features and their in vitro behaviour.  
 
2 Materials and Methods 
 
2.1 Synthesis of starting glasses 
 
In this work, glass-ceramic scaffolds were produced by using two different “specular” glasses, 
hereafter named CEL2 and ICEL2. CEL2 was a silica-based glass belonging to the SiO2–P2O5–
CaO–MgO–Na2O–K2O system [28], whereas ICEL2 was a phosphate-based glass developed by 
modifying the chemical composition of CEL2 [29]. “Specular” glass means that the molar amounts 
of SiO2 and P2O5 in the ICEL2 composition were inverted in comparison to those of CEL2 in order 
to prepare a phosphate glass with small silica content and without any variation of both the modifier 
oxides amounts and the former/modifier oxides molar ratio with respect to CEL2 composition. The 
complete molar compositions of these two glasses are listed in table 1. Both glasses were prepared 
by melting the raw products in a platinum crucible in air; the synthesis details are summarized in 
table 2. The molten glasses were poured on a preheated stainless steel plate; the materials were 
finally ground by ball milling and sieved to obtain powders below 30 m.  
 
2.2 Glasses characterization 
 
The glass transition temperature (Tg), the crystallization temperatures (TXX) and the melting 
temperatures (Tm) of CEL2 and ICEL2 were previously investigated by the authors [28-29]  by 
differential thermal analysis (DTA; DTA7 Perkin-Elmer; temperature range: 50-1200 °C, heating 
rate: 20 °C∙min-1) and are listed in Table III. 
  
CEL2 and ICEL2 underwent wide-angle (2θ within 10-70°) X-ray diffraction analysis (XRD) using 
a X’Pert diffractometer (Bragg-Brentano camera geometry with Cu K incident radiation; working 
conditions: 40 kV, 30 mA). 
 
2.3 Scaffolds fabrication 
 
The polymeric template chosen for scaffolds preparation was a commercial open-cells PU sponge 
(apparent density 20 kgm-3). The polymer was cut into 15.0 × 15.0 × 15.0 mm3 cubic blocks and 
then impregnated with a water-based CEL2 or ICEL2 slurry. The weight composition of both 
slurries was the following: 30% glass, 64% distilled water and 6% polyvinil alcohol (PVA), which 
was used as binding agent to optimize the ability of glass particles to uniformly coat the template. 
First PVA was hydrolyzed in water by continuous magnetic stirring at 60 °C for 1 h and then the 
glass powders were dispersed in the solution; the water evaporated during PVA dissolution was re-
added to the slurry. The sponge blocks were soaked into the glass slurry for 60 s, taken back and 
compressed (20 kPa for 1 s) in the three spatial directions aiming to remove the exceeding slurry. 
This infiltration-compression process was repeated for several times. Finally, the samples were 
dried at room temperature for 6 h and thermally treated in order to remove the organic phase and to 
sinter the inorganic one, thus obtaining macroporous glass-ceramic scaffolds. The thermal treatment 
was set at 1000 °C/3h for CEL2-derived scaffolds and at 610 °C/3h for ICEL2-derived scaffolds 
(heating rate: 5 °C∙min-1 for both thermal treatments). The sintering conditions were chosen on the 
basis of thermal analysis data and hot stage microscopy results [27, 29] to attain a good samples 
densification coupled with the minimum shrinkage. 
 
2.4 Scaffolds characterization 
 
  
XRD analysis was performed on the ground scaffolds to detect the presence of crystalline phases 
after sintering.  
Scaffolds structure and morphology were evaluated through scanning electron microscopy (SEM, 
Philips 525 M) to assess pores size, shape and distribution.  
The volumetric shrinkage Σvol (%), due to the PU template removal and to the glass softening-
sintering, was estimated as 
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where V0 is the volume of the impregnated sponge before the thermal treatment and Vs is the 
scaffold volume. 
The porosity content  (%vol.) was calculated, through geometrical weight-volume evaluations, as  
100







 

g
sg


, 
where g is the density of non-porous glass and s is the apparent density of the scaffold 
(weight/volume ratio). 
The presence of a 3-D network of interconnected pores was qualitatively assessed by means of 
capillarity tests. A face of the scaffold was put into contact with a thin film of calf serum, in which 
some drops of red ink were dispersed to simulate the colour of blood, to verify if the fluid was 
infiltrating the porous network due to capillarity forces. 
The scaffolds strength was evaluated through crushing tests (MTS System Corp. apparatus, cross-
head speed set at 1 mm∙min-1); the failure stress f (MPa) was obtained as  
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where FM (N) is the maximum compressive load registered during the test and Ar (mm
2
) is the 
resistant area perpendicular to the load axis. 
  
Finally, in vitro tests were carried out by soaking the scaffolds in acellular simulated body fluid 
(SBF), prepared according to Kokubo’s protocol [30], that mimics the ion composition of human 
plasma. The samples were soaked for different time frames in 30 ml of SBF maintained at 37 °C; 
the solution was replaced every 48 h to simulate fluid circulation in the human body. The pH 
variations induced by ion-exchange phenomena, were daily monitored (SBF reference value: pH = 
7.40). After soaking, the samples were dried at room temperature and then investigated through 
SEM equipped with EDS system (Philips Edax 9100) for compositional analysis. A quantitative 
evaluation of phosphate scaffolds solubility was attained by weigthing the samples before and after 
soaking and by then calculating the weight loss.  
 
3 Results and discussion 
 
3.1 Starting glasses 
 
CEL2 showed two crystallization temperatures but only one melting temperature, because the two 
crystalline phases melted simultaneously. On the contrary, ICEL2 exhibited one TXX value but two 
Tm values: in this case, the crystalline phases nucleated at the same temperature.  
XRD spectra of as-poured CEL2 and ICEL2, reported in figure 1 and show only a broad halo 
revealing that the starting materials did not contain crystalline phases and are completely 
amorphous glasses.  
 
3.2 Scaffolds structural and morphological characterization 
 
Figure 2 depicts the structure of the PU sponge, used as scaffolds template, that exhibits a 3-D 
network of pores ranging from 200 up to 800 m with trabeculae thickness within 10-50 m. The 
porosity of the sponge, assessed by weight-volume measurements, was ~95 %vol. The polymeric 
  
skeleton was coated with a thin and continuous layer of glass particles (figure 3) in order to obtain, 
after the organic phase removal, an inorganic CEL2-derived or ICEL2-derived replica of the 
template. 
After sintering, the resulting scaffolds were glass-ceramic because the thermal treatment induced 
the nucleation of crystalline phases from the glass amorphous phase, as detected by XRD 
investigations (figure 4). Specifically, in good accordance with previous work [27, 29], the 
crystalline phases were indexed as Na4Ca4(Si6O18) (combeite) and Ca2Mg(Si2O7) (akemanite) for 
glass-ceramic CEL2 (GC-CEL2), and as Na2Mg(PO3)4 and Ca2P2O7 (calcium pyrophosphate) for 
glass-ceramic ICEL2 (GC-ICEL2). It is worth to underline that these phases are well known to be 
highly biocompatible [31-32]. Concerning GC-CEL2, it was demonstrated by other authors that 
crystals of combeite promoted material bioactivity [33] and a combeite-like phase was also found in 
sintered Bioglass

, which has been in clinical use since 1993 as Perioglas
®
, used to fill periodontal 
defects, and as NovaBone
®
, used in orthopaedic applications. [12]. As regards GC-ICEL2, calcium 
pyrophosphate is known to act as precursor of HA or apatite-like phases mimicking bone mineral 
[34-36].  
The presence of two crystalline phases in both GC-CEL2 and GC-ICEL2 scaffolds is consistent 
with thermal analysis data (table 3). In fact, the crystalline phases assessed by XRD investigations 
have an actual correspondence with the crystallization/melting temperatures found via DTA.  
The produced cubic scaffolds are shown in figures 5a-b: the high porosity of the samples is already 
evident from these low-magnification pictures. The grey colour of GC-CEL2 scaffolds is due to 
presence of negligible amount of carbon residual of the PU template due to the low sintering 
temperature.  It should be noticed that the sponge replication method involves a great potential for 
scaffolds fabrication, because the easiness of shaping the starting polymeric template allows to 
produce implants matching the bone defects and tailored to each single patient. 
The effective densification of the pores struts, detected for both scaffolds, demonstrates that a good 
degree of sintering was achieved, as shown in figures 6 and 7. It should be noticed that a higher 
  
degree of sintering was obtained for GC-CEL2 scaffolds (figure 6) in comparison with GC-ICEL2 
scaffolds (figure 7). The obtained 3-D network of open and interconnected macropores, ranging 
within 100-500 m, closely mimics the trabecular morphology of natural cancellous bone. In 
addition, a high interconnection of the macropores plays a key role to promote the fast in vivo 
vascularization of the implant [15]. 
The volumetric shrinkage of the scaffolds due to sintering is reported in table 4. It is a crucial 
parameter for scaffold design and preparation as it allows to tailor the final scaffold in terms of size 
and shape in order to fabricate “patient-designed” grafts. The porosity  reported in table 4 is the 
scaffolds whole pores content including the contribution of both macro- (> 100 m) and micropores 
(< 100 m).  
The low standard deviation found for the volumetric shrinkage and pores content assesses the 
reproducibility of the prepared samples. 
The sequence of pictures shown in figures 8a-e depicts the phases of the capillarity test performed 
on a GC-ICEL2 scaffold. The calf serum went up through scaffold pores network in a couple of 
seconds; similar results were obtained for GC-CEL2 scaffolds. In figure 8f the cross-sections of a 
GC-CEL2 scaffold before and after the test are compared: the presence of the red fluid in the inner 
part of the scaffold further confirms the high interconnection degree of the porous texture. 
 
3.3 Scaffolds mechanical testing 
 
Figure 9 reports two examples of GC-CEL2 and GC-ICEL2 scaffolds stress-strain (σ-ε) curves. 
Both scaffolds exhibited, as foreseen, a failure mode typical for brittle ceramics, i.e. the catastrophic 
failure after the maximum stress. The jagged profile of the curves is due to the progressive cracking 
of scaffolds trabeculae. As regards GC-CEL2 scaffold, the first peak visible in figure 9a can be 
attributed to the fracture of thinner trabeculae, whereas the second peak corresponds to the 
crumbling of thicker trabeculae, according to a mechanism described elsewhere [36].  
  
The failure stresses are reported in table 5. The strength of GC-CEL2 scaffolds is one order of 
magnitude higher than that of GC-ICEL2 scaffolds: this can be attributed both to the different pores 
content, which was higher in GC-ICEL2 scaffolds than in GC-CEL2 ones (table 4), and to the 
intrinsic mechanical properties of GC-CEL2 and GC-ICEL2. In addition, as shown in figures 6 and 
7, a higher degree of sintering was achieved for GC-CEL2 scaffolds with respect to GC-ICEL2 
ones; therefore, the trabeculae of the silicate scaffolds were sounder than those of the phosphate 
ones. 
GC-CEL2 scaffolds were very promising candidates for bone grafting as they closely match the 
pores content and mechanical strength of cancellous bone [10-11]. On the contrary, the strength of 
GC-ICEL2 scaffolds, although being comparable to today’s commercially available ceramic (glass) 
scaffolds such as Bioglass
®
-derived scaffolds [38], is still unsatisfactory for load-bearing implants. 
  
3.4 Scaffolds in vitro behaviour 
 
GC-CEL2 and GC-ICEL2 scaffolds exhibited a different in vitro behaviour due to the peculiar 
properties of the starting glasses composition. 
Figure 10a shows a GC-CEL2 scaffold cross-section after soaking for 7 days in SBF; the sample 
was embedded in epoxy resin (Struers), cut by means of a diamond rotating wheel and finally 
polished by SiC grit papers. A thick layer (20-80 m) of a newly formed phase grown on pores 
walls is clearly distinguishable. EDS investigations (figure 10b) revealed that this layer was 
composed by only calcium and phosphorus with Ca/P molar ratio of 1.66, that closely approaches 
the Ca/P value of natural HA (1.67). The XRD pattern, shown in figure 11, revealed several marked 
peaks that can be actually indexed as the main reflections of HA phase, in accordance with EDS 
results. The two main peaks are broad due to the nano-crystalline nature of HA grown on bioactive 
glasses [39]. Therefore, GC-CEL2 scaffolds are expected to stimulate in vivo cells colonization and 
osteogenesis, as a HA layer promotes osteoblasts adhesion on scaffolds walls [40]. 
  
Figure 12 shows GC-ICEL2 scaffold structure after soaking for 1 month in SBF: scaffold struts 
became thinner and pores size increased because, as expected, the phosphate scaffold underwent an 
erosion process. The weight losses were 8.0  2.0 %, 12.0  2.7 % and 17.0  3.1 %, respectively, 
after soaking for 7, 30 and 90 days in SBF. 
The pH variations in the solution were quite moderate for both scaffolds (pH within 7.30-7.55); 
therefore, no cytotoxic effect is foreseen after in vivo scaffolds implantation. 
 
4 Conclusions 
 
In this work, two kinds of macroporous foam-like glass-ceramic scaffolds, based on a couple of 
silicate-phosphate glasses, were produced via sponge replication method. All samples exhibited 
structure, morphology and pores features (amount, size and shape) analogous to those of cancellous 
bone. The strength of the silica-based glass-ceramic scaffolds is comparable to that of natural bone, 
whereas the strength of the phosphate glass-ceramic scaffolds is one order of magnitude lower. The 
scaffolds showed a quite different in vitro behaviour. The silicate glass-derived scaffolds exhibited 
highly bioactive properties, as a hydroxyapatite layer grew on their surface after soaking in SBF. 
On the contrary, the phosphate scaffolds, being resorbable, underwent a dissolution process.  
Therefore, the proposed scaffolds are interesting for applications in bone tissue engineering as not 
only their shape and size, but also their structure, strength and bioactive/bioresorption can be 
tailored to surgical needs.  
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Figure  
 
Fig. 1 XRD patterns of as-poured glasses: (a) CEL2 and (b) ICEL2 
 
 
 
 
 
 
 
 
 
  
Fig. 2 Bare polymeric template  
 
 
 
 
Fig. 3 Impregnated sponge: (a) CEL2-coated and (b) ICEL2-coated polymer 
 
 
  
 
Fig. 4 XRD patterns of (a) GC-CEL2 scaffold and (b) GC-ICEL2 scaffold 
 
Fig. 5 (a) GC-CEL2 scaffold and (b) GC-ICEL2 scaffold 
 
  
Fig. 6 SEM micrography of GC-CEL2 scaffold 
 
 
Fig. 7 SEM micrography of GC-ICEL2 scaffold 
 
 
  
Fig. 8 Capillarity test: (a)-(e) phases of the test carried out on GC-ICEL2 scaffold; (f) comparison 
between the cross-sections of GC-CEL2 scaffold before and after the test 
 
 
 
 
Fig. 9 Stress-strain curves typical for (a) GC-CEL2 and (b) GC-ICEL2 scaffolds 
 
 
 
 
 
  
Fig. 10 In vitro tests on GC-CEL2 scaffold after 7 days in SBF: (a) scaffold cross-section and (b) 
EDS pattern of the newly formed phase (HA) 
 
 
 
Fig. 11 XRD on GC-CEL2 scaffold after soaking for 7 days in SBF 
 
 
 
  
Fig. 12 Micrography of GC-ICEL2 scaffold after 30 days in SBF 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Tables 
 
Table 1 Composition of starting glasses 
Glass 
Composition (%mol.) 
SiO2 P2O5 CaO Na2O MgO K2O 
CEL2 45 3 26 15 7 4 
ICEL2 3 45 26 15 7 4 
 
 
Table 2 Preparation of starting glasses 
Glass Raw products Melting conditions 
CEL2 SiO2, Ca3(PO4)2, CaCO3, Na2CO3, 
4MgCO3Mg(OH)2·5H2O, K2CO3 
1400 °C for 1 h 
(heating rate: 10 °C∙min-1) 
ICEL2 (NH4)2HPO4, SiO2, Ca3(PO4)2, 
Na3PO4·12H2O, Mg3(PO4)2·8H2O, 
K2HPO4  
1200 °C for 1 h 
(heating rate: 10 °C∙min-1) 
 
 
Table 3 Results of the thermal analysis carried out on CEL2 and ICEL2 
Glass Tg (°C) TXX (°C) Tm (°C) 
CEL2 550 ± 10 760 ± 10; 810 ± 10 1050 ± 15 
ICEL2 410 ± 10 590 ± 10 660 ± 10; 675 ± 10 
 
 
 
 
  
 
Table 4 Features of the produced scaffolds
a
 
Scaffold material Σvol (%)  (%vol.) 
GC-CEL2 64.5  2.0 54.8  4.5 
GC-ICEL2 47.1  3.0 82.0  6.7 
a
 5 scaffolds tested for each series 
 
Table 5 Scaffolds mechanical strength
b
 
Scaffold material f (MPa) 
GC-CEL2 5.2  2.0 
GC-ICEL2 0.4  0.2 
b
 5 scaffolds tested for each series 
 
 
 
 
 
 
